Cargando…

Rapamycin in preventive (very low) doses

Detalles Bibliográficos
Autores principales:	Kondratov, Roman V., Kondratova, Anna A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012933/ https://www.ncbi.nlm.nih.gov/pubmed/24670390

Ejemplares similares

Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1
por: Kondratov, Roman V., et al.
Publicado: (2009)

Circadian clock proteins control adaptation to novel environment and memory formation
por: A.Kondratova, Anna, et al.
Publicado: (2010)

Removal of Endotoxin from rAAV Samples Using a Simple Detergent-Based Protocol
por: Kondratova, Liudmyla, et al.
Publicado: (2019)

BMAL1-dependent regulation of the mTOR signaling pathway delays aging
por: Khapre, Rohini V., et al.
Publicado: (2014)

Metabolic clock generates nutrient anticipation rhythms in mTOR signaling
por: Khapre, Rohini V., et al.
Publicado: (2014)

Rapamycin in mice
por: Swindell, William R.
Publicado: (2017)

Regulation of glucose homeostasis by calorie restriction and periodic fasting
por: Mezhnina, Volha, et al.
Publicado: (2020)

Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
por: Donehower, Lawrence A.
Publicado: (2012)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Multifaceted aging and rapamycin
por: Anisimov, Vladimir N.
Publicado: (2013)

Unleashing rapamycin in fibrosis
por: Hillel, Alexander T., et al.
Publicado: (2015)

Low Dose Rapamycin Exacerbates Autoimmune Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2012)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Shi, Yinan, et al.
Publicado: (2021)

Rapamycin for aging stem cells
por: Hambright, William S., et al.
Publicado: (2020)

Rapamycin protects aging muscle
por: Tang, Huibin, et al.
Publicado: (2019)

Does rapamycin slow down time?
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Rapamycin slows down gut aging
por: Gaur, Uma, et al.
Publicado: (2016)

Low‐dose rapamycin‐induced autophagy in cochlear outer sulcus cells
por: Saegusa, Chika, et al.
Publicado: (2020)

About-face on the metabolic side effects of rapamycin
por: Salmon, Adam B.
Publicado: (2015)

Transient and late-life rapamycin for healthspan extension
por: Quarles, Ellen K., et al.
Publicado: (2020)

Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
por: Li, Jiaming, et al.
Publicado: (2013)

Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats
por: Lu, Zhenya, et al.
Publicado: (2015)

The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
por: Li, Shulin
Publicado: (2009)

Prolonged Rapamycin treatment led to beneficial metabolic switch
por: Fang, Yimin, et al.
Publicado: (2013)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

Biological effects of hadrons at very low doses
por: Baarli, Johan, et al.
Publicado: (1976)

An insight of rapamycin against cadmium’s neurotoxicity
por: Xu, Chong, et al.
Publicado: (2017)

A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis
por: Phillips, Brandon N., et al.
Publicado: (2010)

Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer
por: Lee, Hyung Soon, et al.
Publicado: (2022)

Rapamycin: Killing two birds with one stone
por: Khanna, Amit, et al.
Publicado: (2011)

Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia
por: Koike, Marcia Kiyomi
Publicado: (2019)

Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
por: Siegmund, Stephanie E, et al.
Publicado: (2017)

Rapamycin in lipoproteins for enhanced delivery
por: Cho, Kyung-Hyun
Publicado: (2012)

Cell-autonomous circadian DNA damage response: Is the case closed?
por: Kondratov, Roman V.
Publicado: (2012)

Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia
por: Cao, Tianyu, et al.
Publicado: (2023)

Intermittent supplementation with rapamycin as a dietary restriction mimetic
por: Longo, Valter D, et al.
Publicado: (2011)

Chemoprevention of age-related macular regeneration (AMD) with rapamycin
por: Zheng, X. F. Steven
Publicado: (2012)

Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo
por: Hester, J, et al.
Publicado: (2012)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
por: Ansell, Jack
Publicado: (2017)

Very Sensitive
Publicado: (1856)

Cannot write session to /tmp/vufind_sessions/sess_dl8imt9he4rupvfdc6sjfri1fi